Primary biliary cholangitis: Appraising the changing therapeutic landscape
39:16
Where to next in limited-stage small cell lung cancer? The role of immune checkpoint inhibitors
27:28
Precision targeting of MET in NSCLC: A multidisciplinary approach
13:37
The evolving landscape of Primary Biliary Cholangitis (PBC): new therapies and future directions
57:45
SPECIAL PRESENTATION: Surviving the "Tripledemic" in 2025: COVID, Influenza, and RSV!
33:26
Pharmacological management of agitation in Alzheimer’s dementia
38:00
Navigating the management of cholestatic pruritus in patients with PBC
40:30
Continuous glucose monitoring in type 2 diabetes: Overcoming barriers to optimize outcomes
51:13